This trial will explore giving standard dose chemotherapy and radiation therapy to sites of disease including all lymph nodes involved with HPV-positive oropharyngeal cancer, but administering lower doses of radiation therapy to the lymph nodes that are not known to be involved with cancer.
- Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
- Head and Neck Cancers
- Throat Cancer
- Oropharyngeal Cancers
1 Primary · 6 Secondary · Reporting Duration: At 1 and 2 years post treatment
Awards & Highlights
0 Treatment Group
28 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has this treatment been officially validated by the FDA?
"As this is a Phase 2 clinical trial, an assessment of the safety profile gave rise to a score of 2 due to limited evidence supporting efficacy." - Anonymous Online Contributor
What are the typical indications for this particular therapy?
"Advanced ovarian cancer is frequently treated with this therapeutic intervention, however it can also be employed to treat other maladies such as advanced testicular cancer that have been nonresponsive to conventional treatments and advance directives." - Anonymous Online Contributor
How many participants are currently enrolled in this research study?
"Affirmative. Clinicaltrials.gov has revealed that the trial, which first appeared on 28th September 2020, is presently recruiting participants. Altogether, 28 people need to be enlisted at a single site." - Anonymous Online Contributor
Is this medical experiment currently accepting participants?
"The trial, which was opened on September 28th 2020 and last updated October 31st 2022, is currently seeking participants. Clinicaltrials.gov offers this information for potential candidates to review." - Anonymous Online Contributor
Are there any precedents of this treatment being tested in a medical research setting?
"At present, 689 medical trials are actively researching this treatment with 274 of these studies in Phase 3. Shanghai is one hub for research on the subject but there are over four thousand other sites worldwide conducting relevant experiments." - Anonymous Online Contributor